Opening scene: Examination report
An AMH test report showing 0.8 ng/ml made 32-year-old Ms. Lin realize for the first time that her ovarian reserve might be lower than that of her peers. She had originally planned to start her overseas IVF cycle next month. This report meant that the ovarian stimulation protocol needed to be adjusted from the conventional long protocol to a milder antagonist protocol, and the cycle start date was postponed accordingly. The value of pre-examination lies precisely here—it is not a hurdle to be crossed, but a foundation for decision-making in subsequent treatment.
What does the pre-IVF examination abroad include?
Pre-IVF examinations abroad are divided into three categories: female tests, male tests, and tests for both partners. The core goal is to comprehensively assess fertility, identify factors that may affect IVF success rates, and provide a basis for individualized treatment plans.
Female Examination Items
- Ovarian Reserve Assessment: AMH (Anti-Müllerian Hormone), FSH (Follicle-Stimulating Hormone), LH (Luteinizing Hormone), E2 (Estradiol)
- Ultrasound Examination: Antral Follicle Count (AFC), uterine morphology, endometrial condition, bilateral ovarian volume
- Thyroid Function: TSH, FT3, FT4 (thyroid dysfunction can affect embryo implantation)
- Infectious Disease Screening: Hepatitis B panel, Hepatitis C antibody, HIV, syphilis serology, TORCH
- Coagulation Function: Coagulation四项 (D-dimer may be added for some individuals)
- Hysteroscopy: Recommended for those with recurrent miscarriage, abnormal endometrial morphology, or history of uterine surgery
Male Examination Items
- Semen Analysis: Sperm concentration, progressive motility (PR), normal morphology rate
- Sperm DNA Fragmentation Index (DFI): Reflects sperm nuclear DNA damage; DFI < 15% is considered good
- Infectious Disease Screening: Hepatitis B, Hepatitis C, HIV, syphilis
- Y Chromosome Microdeletion (in some cases): Applicable for severe oligoasthenospermia or azoospermia
Tests for Both Partners
- Chromosomal Karyotype Analysis: Valid for life; recommended for all IVF patients
- Blood Type and Rh Factor: Used for blood preparation and risk assessment of neonatal hemolytic disease
- Routine Health Check: Complete blood count, urinalysis, liver and kidney function, fasting blood glucose
Easily Overlooked Detail: Validity of Examination Reports
One easily overlooked issue in pre-examination is that each test report has a validity period. If a report has expired by the time the cycle starts, it must be redone, which not only increases costs but also causes delays. Especially for older women, every month of delay can affect ovarian reserve status.
| Test Item | Common Validity | Notes |
|---|---|---|
| AMH | 6–12 months | Ovarian reserve changes dynamically; requires regular re-testing |
| Sex Hormone Panel (6 items) | 3–6 months | Varies significantly across menstrual cycle phases; must be tested at specified times |
| Semen Analysis | 6–12 months | Affected by recent health status, fever, medication, etc. |
| Chromosomal Karyotype | Lifetime validity | Does not change over time; no need to repeat |
| Infectious Disease Screening | 6–12 months | Requirements vary by country; some countries require reports within 3 months |
| Thyroid Function | 3–6 months | Must be within normal range; re-test after treatment if abnormal |
Clinical Reminder: Some overseas fertility centers have specific requirements regarding the issuing institution of test reports—for example, they may require reports from a tertiary hospital or a laboratory with specific accreditation. It is advisable to confirm the checklist and institutional qualifications with the destination center before testing to avoid re-testing due to unrecognized reports.
Common Pitfalls in Pre-Examination
Myth 1: Male examination is not important
Clinically, many couples complete all female tests while the male partner delays his examination. In fact, male factors account for about 30%–40% of infertility. Semen analysis is a core indicator for assessing male fertility and cannot be omitted. If the male partner has severe oligoasthenospermia or high DNA fragmentation, ICSI (Intracytoplasmic Sperm Injection) or prior medical treatment may be needed.
Myth 2: Low AMH means giving up on IVF
Low AMH only indicates diminished ovarian reserve, not the inability to obtain viable embryos. The key is to develop an appropriate stimulation protocol and set realistic time expectations. Patients with AMH 0.5–1.0 ng/ml may still retrieve eggs using a mild protocol, and multiple egg retrievals may be considered to accumulate embryos if necessary.
Myth 3: All tests are most convenient to do at home
Some tests are indeed more convenient to do domestically, but certain countries require specific tests (e.g., infectious disease screening, chest X-ray) to be performed locally, or have specific requirements for the issuing institution. Confirming the destination country's specific requirements in advance can avoid finding out that reports are not accepted upon arrival.
Myth 4: Normal test results guarantee success
Pre-examination only assesses baseline conditions. IVF success rates are influenced by multiple factors, including embryo quality, uterine receptivity, laboratory conditions, and hormonal regulation. Normal results do not guarantee success, but they create better conditions for it.
Actual Process of Pre-Examination
The general process for pre-IVF examinations abroad is as follows, with sufficient buffer time needed for each step:
- Initial Consultation: After deciding on the destination country, obtain the complete examination checklist and requirements for report-issuing institutions from the chosen center.
- Domestic Tests: Complete basic tests at a qualified hospital or fertility center, ensuring all items are included.
- Report Translation and Notarization: Some countries require reports to be translated into the local language or English, and some require notarization.
- Report Review: Submit the test reports to the medical department of the overseas fertility center for review.
- Supplementary Tests: Based on the review feedback, additional items or re-testing of expired reports may be needed.
- File Completion: Once all reports are approved, enter the cycle waiting phase and determine the start date.
The entire process typically takes 1–3 months, depending on the completeness of the test items and the speed of report review feedback. It is recommended to confirm report approval before booking flights.
Optimal Timeline
The following timeline is based on clinical experience and is suitable for most people planning overseas IVF:
| Time Point | Tasks to Complete |
|---|---|
| 3–4 months before start | Decide on destination and fertility center, obtain complete examination checklist, understand passport and visa requirements |
| 2–3 months before start | Complete basic tests (AMH, sex hormones, semen analysis, etc.), apply for or renew passport, perform chromosomal karyotype analysis (report takes 10–14 business days) |
| 1–2 months before start | Complete infectious disease screening, submit reports for review, perform supplementary tests based on review results |
| 1 month before start | Confirm all reports are complete and valid, complete file setup, finalize travel plans and medication protocol |
Core Time Planning: Chromosomal karyotype analysis takes the longest (about 10–14 business days), so it should be arranged first. AMH and sex hormone panel can be done together on days 2–3 of the menstrual cycle. Semen analysis requires 2–7 days of abstinence; plan accordingly.
Key Test Indicator Interpretation
AMH (Anti-Müllerian Hormone)
- Reflects ovarian reserve; not affected by menstrual cycle, can be tested anytime
- Normal range: 1.0–4.0 ng/ml (slight variations between laboratories)
- Below 1.0 ng/ml indicates diminished reserve; requires a mild stimulation protocol
- Below 0.5 ng/ml indicates severely diminished reserve; may require multiple egg retrievals
FSH (Follicle-Stimulating Hormone)
- Reflects ovarian response to stimulation medication; must be tested on days 2–3 of the menstrual cycle
- Normal value: < 10 IU/L
- 10–15 IU/L indicates diminished reserve; response may be suboptimal
- > 15 IU/L indicates significantly diminished reserve; requires individualized protocol
Key Semen Analysis Indicators
- Sperm Concentration: ≥ 15 million/ml
- Progressive Motility (PR): ≥ 32%
- Normal Morphology Rate: ≥ 4% (strict criteria)
- DNA Fragmentation Index (DFI): < 15% is good, 15–30% is moderate, > 30% may affect embryo development
Examination Focus in Different Situations
Situation 1: Advanced Age (≥ 35 years)
Key tests: AMH, FSH, antral follicle count, chromosomal karyotype, genetic counseling. Consider adding hysteroscopy and endometrial receptivity assessment to rule out uterine pathology. The older the age, the higher the risk of oocyte aneuploidy, and the greater the need for preimplantation genetic testing for aneuploidy (PGT-A).
Situation 2: Low AMH (< 1.0 ng/ml)
Key tests: After confirming AMH, focus on evaluating antral follicle count and previous response to stimulation. No additional special tests are needed, but time expectations should be adjusted—multiple egg retrievals may be required to accumulate embryos. The key is to find a fertility center experienced in mild stimulation protocols.
Situation 3: History of Recurrent Miscarriage
Key tests: Chromosomal karyotype for both partners, immune-related markers (antiphospholipid antibodies, NK cell activity, etc.), coagulation function, hysteroscopy. Consider adding genetic counseling to evaluate potential causes of recurrent miscarriage.
Situation 4: Male Factor
Key tests: Semen analysis, sperm DNA fragmentation index, Y chromosome microdeletion. If semen quality is severely abnormal (e.g., severe oligoasthenospermia or azoospermia), consider ICSI or donor sperm options, and evaluate the need for testicular sperm extraction.
Frequently Asked Questions
Q1: Do I need to prepare before overseas IVF?
Yes. It is recommended to start taking folic acid (0.4–0.8 mg daily for women) and antioxidants (such as vitamin E, CoQ10 for men) 3 months in advance. Also adjust lifestyle: regular sleep, balanced diet, quit smoking and limit alcohol, avoid high-temperature environments (sauna, hot baths). Those with a body mass index (BMI) outside the normal range should consider appropriate adjustments.
Q2: What are the passport validity requirements for overseas IVF?
Generally, a passport must be valid for at least 6 months; some countries (e.g., Thailand) require at least 9 months. Check your passport's validity early and renew it if necessary. Also confirm whether a visa is required for the destination country and the processing time.
Q3: What documents are needed for overseas IVF file setup?
Typically required: original and copy of both partners' ID cards, marriage certificate (notarized translation required in some countries), passport and visa, all test reports (original + translation), and in some countries, a notarized marriage certificate or birth certificate. The specific list depends on the destination country and the fertility center's requirements.
Q4: Can I still do overseas IVF with low AMH?
Yes. Low AMH does not mean IVF is impossible; it simply requires a milder ovarian stimulation protocol and may involve multiple egg retrievals to accumulate embryos. The key is to find a suitable fertility center and an experienced doctor; standardized high-dose protocols are not recommended.
Q5: Does the male partner need to stay abroad for the entire cycle?
It depends on the plan. If the male partner's semen is normal, he can arrive 2–3 days before egg retrieval and return home after providing the sample. If special semen processing is needed or there is difficulty in providing a sample, allow more time. Some centers support sperm freezing, allowing the male partner to provide and freeze sperm before the cycle starts.
Ending: Examination reminder
Examination Reminder: Pre-examination is a critical step before starting an overseas IVF cycle. The completeness and timeliness of the tests directly affect whether the cycle can start on schedule. It is recommended to begin preparations 3–4 months in advance and complete each test step by step according to the timeline. If you have concerns about any test result, consult a fertility specialist before deciding on the next steps. Medical requirements vary by country; always follow the latest requirements of your destination fertility center.
Comments (0)